Moors & Cabot, Inc. Myriad Genetics Inc Transaction History

Moors & Cabot, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$29.97 - $36.66 $299,700 - $366,599	10,000 New	10,000 $10,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $425,962 - $616,609	-15,350 Closed	0 $0
Q1 2018 May 18, 2018	SELL	$28.83 - $41.01 $153,519 - $218,378	-5,325 Reduced 25.76%	15,350 $454,000
Q3 2017 Nov 16, 2017	SELL	$24.01 - $36.2 $19,208 - $28,960	-800 Reduced 3.73%	20,675 $744,000
Q2 2017 Aug 15, 2017	BUY	N/A	21,475	21,475 $557,000

228

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $798M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.